This method aids in the treatment of prostate cancer because encouragement of prostate cancer cell development necessitates the generation of testosterone through a signaling pathway that initiates with hypothalamic GnRH secretion [376]. This evidence concerns the gene GNRH1 and Familial prostate cancer.